SCHEMBL6721158

SCHEMBL6721158

Nc1ccc(O)c2cnsc12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 2/20 0.44
KAT2B Q92831 2/20 0.44
KAT8 Q9H7Z6 2/20 0.44
IDO1 P14902 3/20 0.42
HDAC3 O15379 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
PSMB5 P28074 1/20 0.35
GAA P10253 1/20 0.32
THRB P10828 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
CSNK2A3 Q8NEV1 1/20 0.32
CYP3A4 P08684 1/20 0.31
ALOX15 P16050 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11246263 0.83 TDO2 (0.33) EP300KAT2BKAT8CYP3A4HSD17B10
SCHEMBL28176846 0.83 IDO1 (0.36) EP300KAT2BKAT8IDO1GAA
SCHEMBL5448026 0.76 GAA (0.38) GAACYP3A4
SCHEMBL4808435 0.76 OPRK1 (0.36) IDO1
SCHEMBL11470037 0.72 IDO1 (0.47) EP300KAT8IDO1GAATHRB
SCHEMBL911117 0.68 KDM4E (0.39)
SCHEMBL6721139 0.67 IDO1 (0.45) EP300KAT2BKAT8IDO1HDAC3
SCHEMBL9615205 0.66 TDO2 (0.33) HSD17B10
SCHEMBL3873266 0.63 EP300 (0.39) EP300KAT2BKAT8IDO1HDAC3
SCHEMBL5439074 0.63 CYP3A4 (0.39) GAACYP3A4ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4189433-A ADRENERGIC BLOCKING AGENTS BASF AKTIENGESELLSCHAFT (DE) 1980-02-19 US claimed
US-6673122-B1 CONTAINING OXIDIZER L'ORÉAL (FR) 2004-01-06 US disclosed
US-4189433-A ADRENERGIC BLOCKING AGENTS BASF AKTIENGESELLSCHAFT (DE) 1980-02-19 US disclosed